share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

福泰制药 | 4：持股变动声明-高管 Bozic Carmen
美股sec公告 ·  07/25 16:10
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. (VRTX) EVP and CMO, Carmen Bozic, completed a sale of 2,280 shares of company stock on July 24, 2024. The transaction was executed at a price of $488.46 per share, resulting in a total sale value of $1,113,688.80. Following the sale, Bozic's direct holdings in Vertex Pharmaceuticals totaled 25,539 shares. The sale took place through an open market transaction, as reported in the company's filing.
Vertex Pharmaceuticals Inc. (VRTX) EVP and CMO, Carmen Bozic, completed a sale of 2,280 shares of company stock on July 24, 2024. The transaction was executed at a price of $488.46 per share, resulting in a total sale value of $1,113,688.80. Following the sale, Bozic's direct holdings in Vertex Pharmaceuticals totaled 25,539 shares. The sale took place through an open market transaction, as reported in the company's filing.
福泰制药公司（VRTX）的执行副总裁兼首席医疗官Carmen Bozic于2024年7月24日出售了2,280股公司股票。交易价格为每股$488.46，总销售额为$1,113,688.80。 在此次出售后，Bozic在Vertex Pharmaceuticals的直接持股总数为25,539股。该交易是通过公开市场交易进行的，如公司的报告所述。
福泰制药公司（VRTX）的执行副总裁兼首席医疗官Carmen Bozic于2024年7月24日出售了2,280股公司股票。交易价格为每股$488.46，总销售额为$1,113,688.80。 在此次出售后，Bozic在Vertex Pharmaceuticals的直接持股总数为25,539股。该交易是通过公开市场交易进行的，如公司的报告所述。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息